MMC exceeds new medication therapy management quality expectations

Medication Management Center logo (block The College of Pharmacy’s Medication Management Center posts strong ratings relative to new quality standards recently announced by the Centers for Medicare and Medicaid Services (CMS).

On Dec. 18, CMS published data showing how Medicare contracts performed in 2011 relative to the first medication therapy management quality measure, called the Comprehensive Medication Review (CMR) completion rates.

“We are excited to report that 93 percent of the contracts for which we provide medication therapy management services are above the 50th percentile for CMR completion rates based on the industry rates published by CMS,” says Kevin Boesen, director of the Medication Management Center. “Additionally, our center provided services to more than 300,000 medication therapy management members in 2011, representing 10 percent of all reported contracts.”

Center leaders are enthusiastic about the recent release of the CMR rates and pleased to have represented a large client base with strong performance. Operational changes in 2012 have further increased CMR completion rates for the group’s clients. 

“With our experienced pharmacist-run call center and dedicated IT infrastructure, we are able to quickly adapt and respond to new industry standards while maintaining our focus on the patient,” says Boesen.

The addition of the new CMR rate has highlighted the ability of the center to quickly respond to new requests from CMS and operationalize changes to meet the new requests for clients. Another differentiator for the Medication Management Center is its pending URAC* accreditation, which will be completed during 2013. Achieving URAC accreditation will be a strong marker of quality, Boesen says.

 

What is a Comprehensive Medication Review?

At the MMC, a Comprehensive Medication Review is an interactive, person-to-person meeting which includes a registered pharmacist’s analysis of all of the medications a patient is taking to look for potential problems (such as drug-drug interactions), better medication optimization (such as different dosages or formulas) and possible cost savings (such as substituting a less expensive drug for an equivalent medication). 

The review includes a follow-up summary report provided to the patient after the meeting. The CMR may also result in medication change recommendations being made by the pharmacist to the patient and/or the patient’s healthcare provider. The goal of the CMR is to maximize the benefit of a patient’s pharmaceutical care.

 

For more information about CMR ratings, contact Lisa Hettich Barnhart of the UA Medication Management Center, 765-526-2861.

*The UA Medication Management Center has applied for Drug Therapy Management Accreditation from URAC, a Washington, D.C.-based healthcare accrediting organization that establishes quality standards for the healthcare industry.

Share This